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Protein synthesis is an integral part of the pathway of gene expression and makes 
important contributions to modulation of the expression of specific genes (1, 2). Being a 
highly energy demanding process, rates of global protein synthesis must be controlled in 
order to be in accord with the overall metabolic activity of the cell (3). The dominant 
mechanism of control of global protein synthesis is phosphorylation/dephosphorylation of 
translational components, primarily initiation and elongation factors ( 4, 45). It is generally 
believed that the rate limiting step of protein synthesis under most physiological conditions 
is the initiation phase (5, 6). To date, studies on the phosphorylation of the a subunit of the 
eukaryotic initiation factor 2 (eiF-2) constitute one of the best characterized regulatory 
mechanisms known. In order to understand how translation is regulated at this level, 
knowledge of the mechanism of protein synthesis is required and is thus briefly described 
below (7). 
In eukaryotic cells, the translation of mRNA occurs in the cytoplasm. It can be 
divided into three phases, namely initiation, elongation and termination, which are 
promoted by the action of a group of protein factors known as initiation factors (eiFs), 
elongation factors (eEFs) and a release factor (eRF, also termination factor), respectively. 
In the first step of initiation, free eukaryotic 80S ribosomes are in equilibrium with their 
40S and 60S subunits. eiF-3 and eiF-4C shift the equilibrium towards ribosome 
dissociation by binding to the 40S subunit and thus inhibiting the joining of the 60S 
subunit (8). The resulting structure is the 43S ribosomal complex. eiF-6 is thought to act 
similarly by reacting with 60S rather than 40S subunits (9). In the next step, eiF-2 binds 
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GTP and the initiator tRNA, Met-tRNAi (also Met-tRNAr), in a ternary complex (10). 
Ternary complex formation is the committed step of initiation. The resulting complex can 
then bind to the 43S ribosomal complex to form the 43S preinitiation complex (11). 
On the other hand, mRNA forms a complex with eiF-4A, eiF-4B and eiF-4F in an 
A TP-dependent reaction. eiF-4F is believed to be the 5'-cap binding protein, while eiF-4A 
and eiF-4B are A TP-dependent helicases which are thought to play a role in melting mRNA 
secondary structures (12, 13). The 48S preinitiation complex is formed upon binding of the 
mRNA complex to the 43S preinitiation complex near the 5'-cap structure. The 40S 
ribosomal subunit subsequently scans down the mRNA to select the proper start site. The 
anticodon of the Met-tRNAi probably participates in the scanning and recognition of the 
AUG start codon. The joining of the 48S preinitiation complex and the 60S subunit is 
catalyzed by eiF-5 which has a ribosome-dependent GTPase activity. The joining reaction 
is accompanied by the release of the eiF-3, eiF-4C and eiF-2·GDP binary complex (14). 
The formation of the resulting 80S initiation complex completes the initiation phase of 
translation. However, the released eiF-2·GDP binary complex is nonfunctional in 
translational initiation. To reutilize eiF-2 in the subsequent rounds of initiation, the bound 
GDP must be substituted by GTP (15). At physiological concentration of Mg2+ (> 1 mM), 
the binding affinity of eiF-2 for GDP is approximately 400-fold greater than that for GTP 
(Kd GDP ~ 5.0 x 10-9M versus K.J GTP- 1.6 x 10-6 M) (16), and eiF-2·GDP is so stable 
that the bound GDP dissociates at an unusually slow rate (t112 > 30 minutes at 30°C) (17). 
This difference in affinity and the slow dissociation rate of the eiF-2·GDP complex under 
physiological conditions makes it necessary to have another initiation factor, eiF-2B (also 
referred to as "RF", or "GEF") to catalyze the GDP-GTP exchange reaction for eiF-2 
recycling. 
One apparent exception to this general scheme is wheat germ extracts (44), where 
eiF-2 has been found to have four rather than three subunits and its affinity for GOP is 
only 10 times higher than that for GTP (Kc~ GTP ~ 1.5 x 10-6 M), suggesting that at a 
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sufficiently high [GTP]/[GDP] ratio, the guanine nucleotide exchange reaction in wheat 
germ cells may take place without other specific factors such as eiF-2B. 
Phosphorylation of the a-subunit of the eiF-2 is believed to be a general pathway in 
controlling global protein synthesis. Extensive research has been done in the rabbit 
reticulocyte lysate in vitro translation system. Phosphorylation of eiF-2a has no effect on 
the binding affinity of eiF-2 for GDP (18), nor does it affect spontaneous dissociation of 
GDP from eiF-2 (19). Rather, eiF-2(aP)·GDP binds tightly to eiF-2B to form a complex 
whose GDP is readily exchangeable yet the eiF-2B in the resulting eiF-2(aP)·eiF-2B 
complex is essentially nondissociable and thus nonfunctional (19). Since eiF-2B is present 
in lysates at a much lower concentration than eiF-2 (20), phosphorylation of only 20-40% 
of the eiF-2a present is sufficient to bind all the available eiF-2B in a nonfunctional 
complex. This will effectively impede eiF-2 recycling and shut off global protein synthesis. 
The single phosphorylation site on the eiF-2a has been identified as residue Ser-51 
(21). Two kinases are specific for eiF-2a in reticulocyte lysate, the heme-regulated eiF-2a 
kinase (HRI) and the double-stranded RNA activated inhibitor (DAI or dsl). HRI is 
activated in response to hemin deficiency, addition of oxidized glutathione, heavy metals, 
and heat shock (7, 22-24), while DAI is sensitive to low levels of dsRNA (25, 26). 
Activation of either of these two kinases results in the phosphorylation of the same Ser-51 
residue of eiF-2a, followed by an abrupt decline in protein synthesis rate and 
disaggregation of polyribosomes. On the other hand, a protein phosphatase (classified as 
type-2A) (27) for eiF-2(aP) exhibits broad specificity (28). Also temporal correlations of 
phosphorylation and activity have been made, a change in factor activity has been 
demonstrated in vitro (29), and in vivo evidence has been generated for a role in 
translational control (30). All of these provide a convincing although possibly incomplete 
explanation for translational repression by HRI or DAI. 
Elucidation of the mechanisms controlling the rate of protein synthesis in other cells 
has lagged somewhat behind the studies with reticulocytes. However, it is becoming clear 
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that regulation at the level of eiF-2 function is by no means unique to the reticulocyte. 
Kinases and phosphatases acting on eiF-2a have been identified in a wide variety of cells 
and tissues (31-35); eiF-2B preparations with very similar activity and subunit structure to 
the reticulocyte factor have been isolated from Ehrlich ascites cells (36) and rat liver (37) 
and a protein fraction with eiF-2B activity has been obtained from neuroblastoma cells 
(38). It is probably true that altering eiF-2B activity via eiF-2a phosphorylation is a 
general mechanism of controlling global protein synthesis used by many, if not ail , 
eukaryotic cells. 
Although a regulatory role for eiF-2B in global protein synthesis has been 
implicated, the story is possibly incomplete. Substantial variation of the eiF-2B/eiF-2 ratio 
in different cell types and different levels of eiF-2a phosphorylation in different cell types 
have been observed, raising the possibility that a component limiting in one cell type or 
physiological state may not be limiting in another. If this is true, the reason for this 
difference needs to be found. Also, the subcellular distribution and concentration of eiF-2B 
and eiF-2 remains unclear. The central assumption that eiF-2B is far less abundant than 
eiF-2 can only be stated confidently after these issues are resolved. For the protein itself, 
its reaction mechanism, the exact nature of its interaction with both phosphorylated and 
dephosphorylated eiF-2, its interaction with possible cofactors or allosteric regulators (22, 
41), the specific role of its five subunits, and the possible physiological role of 
phosphorylation on its 82-kDa subunit (eiF-2Be) remain to be determined. This study 
seeks to understand the structure and function of human eiF-2B by cloning and sequencing 




The eukaryotic initiation factor 2B (eiF-2B, also referred to in the literature as RF, 
or GEF) is a nonribosomal associated multipolypeptide factor consisting of 5 asymmetric 
subunits with approximate molecular weights of 82, 65, 55, 40, and 32 kDa respectively 
(18, 19, 36, 39, 40). Purified from both post ribosomal supernatants and ribosomal salt 
washes, elF-2B has been isolated in either a free form or complexed in a 1:1 stoichiometry 
with eiF-2 (18, 19, 36, 39-41). In all cases, eiF-2B shows similar subunit composition, 
although slight variations in the molecular weights of the individual subunits have been 
observed in different labs. All five subunits appear to exist in equal molar amounts. This 
conclusion is further supported by the agreement between its calculated molecular weight of 
274 kDa and its apparent molecular weight of about 250 kDa determined by sucrose 
gradient centrifugation (40). The purified eiF-2·eiF-2B complex has an apparent molecular 
weight of 450 kDa and a calculated molecular weight of 418 kDa and this complex can be 
dissociated at high salt concentrations ( 40). The reason for the slight disagreement between 
450 kDa and 418 kDa is unclear although impurities and/or true missing structural 
components have been proposed to account for the difference ( 40). 
At least two subunits of eiF-2B can be phosphorylated. The 82 kDa £ subunit can 
be phosphorylated by casein kinase II in vitro in the presence of A TP ( 42). The extent of 
phosphorylation is 0.55 mole of phosphate per mole of eiF-2B, and this results in a 
2.3 fold increase in eiF-2B activity. Alkaline phosphatase treatment will reduce the activity 
of this protein by a factor by 5. These observations suggest that eiF-2B phosphorylation 
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contributes to the control of eiF-2 recycling, although it is not known if eiF-2Be subunit 
phosphorylation is regulated in vivo. The 65 k:Da 8 subunit can also be phosphorylated. 
This has been suggested to be autophosphorylation by an intrinsic kinase activity of 
eiF-2B. The functional significance of this phosphorylation is not known (18). 
Photochemical labeling with the 8-azidopurine analogs reveals that the 40 kDa ~ 
subunit of eiF-2B binds GTP, and that the 55 kDa "(and the 65 kDa 8 subunits bind 
A TP· Mg2+ and NADP+ interferes with these bindings. Spectrofluorometric analysis of 
eiF-2B suggests that NADPH is bound to eiF-2B in a 2:1 ratio (41). The binding of 
NADPH can be enhanced by glycerol, dithiothreitol and limited dialysis. The fmdings that 
NADH or NADPH have no effect on eiF-2B activity, while NAD+ or NADp+ inhibit the 
GTP-dependent nucleotide exchange reaction, raise the possibility that eiF-2B activity can 
be regulated by the redox state of the cell. However, further in vivo studies are required to 
make this issue clear. 
eiF-2B is generally believed to exist in the cytoplasm and is defined as a 
nonribosomal associated initiation factor. But recent observations have indicated that 
eiF-2·GDP binds tightly to the 60S ribosomal subunit. The dissociation of eiF-2·GDP 
complex from 60S subunit is promoted by eiF-2B (46), suggesting eiF-2B may also 
interact transiently with 60S subunit. In fact, the inability of eiF-2B to dissociate 
eiF-2(aP)·GDP from 60S subunit has led to the proposal that inhibition of protein 
synthesis due to eiF-2a phosphorylation is mediated, at least in part, by this mechanism 
(47). However, a different view is held by other authors who doubt the role of 60S 
ribosomal subunits as the direct carrier of eiF-2·GDP in the release and recycling of eiF-2 
in initiation reactions (48). So the biological function of the association of eiF-2 or 
eiF-2·eiF-2B with 60S ribosomal subunits remains unclear. 
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Proposed Catalytic Mechanisms of eiF-2B 
The precise mechanism by which eiF-2B catalyzes the guanine nucleotide exchange 
reaction is not clearly understood. Various models have been proposed (65-74), yet the 
exact sequence of events involved during the exchange reaction has not been clearly 
established. The overall reaction catalyzed by eiF-2B may be written as 
eiF-2·GDP + GTP ++ eiF-2·GTP + GDP 
The most common model for a two-substrate -two-product reaction may be either a 
sequential or a ping pong mechanism, with the sequential model as being far the more 
common one. 
Ochoa (65) proposed that the eiF-2B catalyzed reaction follows a ping pong 
mechanism in which eiF-2B binds eiF-2·GDP to form a ternary complex. Then GDP is 
released after which GTP is bound. eiF-2B then releases eiF-2·GTP which in turn forms a 
ternary complex with Met-tRNA;. 
Another ping pong mechanism suggested by Safer (69) is quite similar, but differs 
rn that the functioning eiF-2B exists inside a ternary complex including eiF-2 and 
GTP/GDP. The eiF-2·GDP complex displaces eiF-2·GTP bound to eiF-2B, to give 
eiF-2·GDP·eiF-2B. GTP then replaces the GDP inside this complex to regenerate the 
active eiF-2·GTP·eiF-2B ternary complex. The eiF-2·GTP that is released is used to form 
elF-2 ·GTP· Met-tRNA;. 
The ping pong model of Salimans et at (67) is the same as that of Ochoa, except 
after the addition of GTP to the eiF-2·eiF-2B complex. In this model, Met-tRNA; 
subsequently joins to form a quaternary complex. Upon binding of the 40S ribosomal 
subunit, eiF-2B is released while eiF-2·GTP·Met-tRNA; stays on the ribosome. 
Enzyme kinetic data from Henshaw's lab (71) support a ping pong mechanism as 
the mode of eiF-2B function. This mechanism proposes the existence of a 
eiF-2B·eiF-2·GDP complex and excludes the possibility of two guanine nuceotide binding 
sites on eiF-2. 
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A sequential model has been proposed by Goss (68) et a!., in which both 
eiF-2·GDP and GTP must be bound by eiF-2B before any product is released. The 
product, eiF-2·GTP is quickly used to form eiF-2·GTP·Met-tRNA; ternary complex. 
Recently, Dholakia eta!. (72) have found that eiF-2B is a GTP binding protein. Based on 
this observation and other data, a sequential model has been proposed for the guanine 
nucleotide exchange reaction. However, further information concerning substrate addition 
order (random or ordered) is not available. 
Each of these models has been proposed on the basis of experimental data, yet no 
study has been definitive. The uncertainty may be due to several factors: the purity of the 
eiF-2B preparations; the instability of eiF-2B (66, 71); and the possible existence of more 
complicated mechanisms. Also, the activity of eiF-2B can be regulated by a variety of 
effectors (see below) which might somehow affect the reaction mechanism. Furthermore, 
the role of eiF-2B in protein synthesis is likely to be more complex than simply to increase 
the rate of GOP release. As reported by other investigators (46), eiF-2B may affect the 
binding of eiF-2 to 40S subunits and it may also have additional functions while 
complexed with ribosomal subunits. 
Interestingly, analogous reaction mechanisms have been found in other systems. 
Investigators favoring the ping pong model point out that bacterial elongation factor EF-Ts 
displaces GDP from EF-Tu·GDP complex (76) by a mechanism similar to that which they 
propose, while those supporting the sequential model argue that the eukaryotic receptor 
G-protein system (75) may be considered analogous to the eiF-2B catalyzed reaction. 
Regulation of eiF-2B Activity 
The guanine nucleotide exchange activity of eiF-2B is mainly regulated by 
phosphorylation of the a-subunit of eiF-2 (7). Upon phosphorylation, eiF-2(aP)·GDP 
forms a tight complex with eiF-2B which is not readily dissociable (19). Since eiF-2B is 
believed to be much less abundant than eiF-2, phosphorylation of only a part of the eiF-2a 
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present is sufficient to abolish all available eiF-2B activity. Although originally studied in 
the rabbit reticulocyte lysate system, this mechanism is believed to be a general pathway in 
controlling global protein synthesis in many, if not all, eukaryotic cells. However, 
exceptions to this mechanism may exist In the wheat germ system, eiF-2 has been isolated 
as a four (rather than a three) subunit factor. The 40 kDa ~-and 42 kDa y-subunits, but not 
the 37 kDa a-subunit can be readily phosphorylated by the dsRNA activated kinase (DAI) 
from rabbit reticulocytes ( 44). Furthermore, the affinity of eiF-2 for GDP is only 10 times 
that for GTP, making it possible that the GDP-GTP exchange at high [GTP]/[GDP] ratios 
may not require e1F-2B. These observations suggest that eiF-2B activity in wheat germ 
may not be regulated by phosphorylation of eiF-2 subunits. Another exception might arise 
from the controversial role played by 60S ribosomal subunit mediated interaction between 
eiF-2·GDP and eiF-2B ( 47, 48). The possible existence of other pathways for controlling 
global protein synthesis via eiF-2a phosphorylation may account for the substantial 
variations in the eiF-2/eiF-2B ratio observed and the different levels of eiF-2a 
phosphorylation in different eukaryotic cells (20, 31, 49). Clearly, there is still a great deal 
to learn concerning this. 
Two kinases specific for eiF-2a and one phosphatase with broad specificity have 
been implicated in regulating the phosphorylation status of eiF-2a. HRI is active in 
response to hemin deficiency, addition of oxidized glutathione, heavy metals, methylene 
blue and heat shock, while DAI is activated by low levels of dsRNA. Both activated 
kinases phosphorylate the same Ser-51 residue on eiF-2a. Inhibition of eiF-2a 
phosphatase activity, while eiF-2a kinase activity remains unchanged, has also been 
reported to affect eiF-2B activity via changing the status of eiF-2a phosphorylation in rat 
livers deprived of single essential amino acids (50). In other studies, vasopressin (51) and 
mobilization of sequestered Ca2+ in the endoplasmic reticulum in rat liver (52), and a 
temperature sensitive mutation in Leu-tRNA synthetase in Chinese Hamster Ovary cells 
(53) have been demonstrated to cause changes in eiF-2a phosphorylation status. However, 
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the specific signal transduction pathways involved need to be identified. Since kinases and 
phosphatases acting on eiF-2a have been identified in a wide variety of cells and tissues 
(31-35), regulation of eiF-2B activity via regulating eiF-2a phosphorylation status through 
eiF-2a kinases and phosphatases is likely a general mechanism adopted by many other 
eukaryotic cells, although it is not yet clear if other kinases or phosphatases are also 
involved. 
eiF-2B activity may also be regulated by various other factors without changing 
eiF-2a phosphorylation status. Glucose-6-phosphate (Glc-6-P) has been demonstrated to 
be required for maintaining active states of translation (22), but its mechanism of action is 
currently unsettled. Jackson et al (54) concluded that Glc-6-P has a dual role: it is required 
to provide a suitable reducing system; and, in addition, sugar phosphate has some 
unknown activating role on chain initiation. The reducing system is required to maintain 
HRI in an inactive form (54). In addition, Gross et al (56) demonstrate that Glc-6-P 
regulates, perhaps directly, the activity of eiF-2B in a manner that is independent of eiF-2a 
phosphorylation. If this is true, it may also account for the observed ability of insulin to 
stimulate eiF-2B activity in rat fast twitch fiber (57). Given the central position of Glc-6-P 
in glycolysis and the pentose phosphate pathway, the effect of Glc-6-P on eiF-2B activity 
might well integrate the rate of global protein synthesis with carbohydrate metabolism in the 
cell. 
A variety of evidence suggests that redox potential may affect protein synthesis 
activity by influencing eiF-2B activity without changing of eiF-2a phosphorylation status. 
Regeneration of NADPH is known to be required for protein synthesis (22), and NADPH 
has been suggested to be an allosteric regulator of eiF-2B activity (41). However, other 
evidence suggests that NADPH itself may not be responsible for increased eiF-2B activity 
(58) . In in vitro studies, the exchange of eiF-2-bound GOP is markedly inhibited by NAD+ 
and NADP+ and restored by NADPH (41). But eiF-2B activity in this system is dependent 
on the presence of Glc-6-P (56). In another study, where eiF-2a phosphorylation status 
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was not related to the eiF-2B activity, inhibition of protein synthesis in mixed fiber muscles 
of diabetic rats has been proposed to involve a change in the phosphorylation status of 
eiF-2B£ subunit or a change in the NADPH/NADP+ ratio (59). However, the mechanism 
by which redox potential and NADPH affect eiF-2B activity is still unclear. 
Met-tRNAi is also required for efficient recycling of eiF-2·GDP to eiF-2·GTP 
under physiological conditions (60). It is believed that Met-tRNAi stabilizes the exchange 
reaction product eiF-2·GTP by forming a Met-tRNAi·eiF-2·GTP ternary complex. 
Polyamines also appear to regulate eiF-2B activity (61). Although the precise 
mechanism of action is unclear, it has been proposed that polyamines exert their effect by 
regulating casein kinase II (62) which in turn activates eiF-2B (42). 
In reticulocyte lysate, amino acid deficiency may lead to reduction of eiF-2B 
activity while no change in eiF-2a phosphorylation is observed (61). The reduction of 
eiF-2B activity is insufficient, by itself, to slow the rate of protein synthesis. The 
translational inhibition is exerted on polypeptide chain elongation, not initiation, suggesting 
that amino acid deficiency regulates eiF-2B activity by a different mechanism. This seems 
to have changed in nonerythroid cells. A study on a temperature-sensitive tRNALeu 
synthetase mutant of Chinese Hamster Ovary cell shows that reduction in eiF-2B activity is 
associated with an increased level of eiF~2(aP) (62). However, recharging tRNALcu 
in vivo at non-permissive temperature failed to reverse the inhibition of eiF-2 function, 
indicating that tRNA charging per se is not involved in the regulatory mechanism. In 
addition, aging has been shown to decrease eiF-2B activity in rats. No clear mechanism is 
available for this effect (64). 
Given their important roles in controlling global protein synthesis, it is not 
surprising to see that so many factors can exert effects on eiF-2 and eiF-2B, either directly 
or indirectly. Such is in accord with the notion that protein synthesis must be controlled and 
integrated into the overall metabolic activity of the cell in order to respond properly to many 
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different stimuli, including environmental stresses, viral infection, and developmental 
signals. 
Yeast eiF-2B Analog 
Much of the information concerning protein synthesis regulation in yeast comes 
from the study of the control of amino acid biosynthesis. In response to amino acid 
starvation, the budding yeast Saccharomyces cerevisiae increases expression of the GCN4 
protein, which in turn activates transcription of more than 30 genes encoding enzymes 
involved in amino acid biosynthesis (general amino acid control). Such increased 
expression of GCN4 is primarily regulated at the level of translation initiation (77). Four 
upstream open reading frames (uORFs) in the leader of GCN4 mRNA couple GCN4 
translation to the level of eiF-2 activity (78). Under non-starvation conditions, it appears 
that ribosomes scanning from the 5' end of GCN4 mRNA translate the first ORF and 
reinitiate at one of the three remaining uORFs instead of at the GCN4 start codon. Under 
starvation conditions, the GCN2 eiF-2o: kinase becomes activated and phosphorylates 
yeast eiF-2a. In the presence of low levels of functional eiF-2·GTP·Met-tRNAi ternary 
complexes, ribosomes scanning downstream from uORFl skip u0RF2 to -4 and reinitiate 
further downstream at the GCN4 start codon (79). Thus, a decrease in the eiF-2 activity 
(and thus the efficiency of reinitiation) leads to an increase in GCN4 translation. 
In higher eukaryotes, exchange of GDP for GTP is catalyzed by eiF-2B, a five 
subunit protein. A high molecular weight "GCD complex" associated with eiF-2 that 
contains GCD1, GCD2 and GCN3 was postulated to be eiF-2B inS. cerevisiae (80). 
Recently, two new essential genes, GCD6 and GCD7, have been identified inS. cerevesiae 
(81). Although direct biochemical experiments will be required to demonstrate an 
association of GCD6 and GCD7 with other GCD factors, many observations strongly 
suggest that GCD6 and GCD7 are additional subunits of the GCD complex. The most 
convincing evidence is the discovery that GCD6 is 30% identical in sequence to the 82 kDa 
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subunit of rabbit eiF-2B, with the greatest similarity occurring at their amino termini. The 
quality score for GCD6 aligned with eiF-2Bc: was 36 standard deviations above the mean 
score for the randomized sequences, indicating a very high level of statistical significance 
for the sequence similarity between GCD6 and eiF-2Bc:. 
In higher eukaryotes, phosphorylation of eiF-2a plays an important role in 
controlling global protein synthesis according to the sequestration model (7). Dever eta/ 
(79) found that the yeast protein kinase GCN2 stimulates GCN4 translation in amino acid 
starved cells by phosphorylating eiF-2a on Ser-51 residue. This evidence together with the 
finding that GCN2 is homologous to rabbit reticulocyte HRI and human DAI (82) strongly 
suggest that GCN2 plays a role in global regulation of protein synthesis in yeast by 
controlling phosphorylation status of yeast eiF-2 in response to signals such as amino acid 
starvation. 
The observation that the budding yeast S. cerevisiae has a mechanism for regulating 
global protein synthesis which is quite similar to that of many higher eukaryotes, suggests 
that this mechanism is likely to be of vital importance since it is conserved from yeast to 
human. 
CHAPTER III 
MATERIALS AND ME1HODS 
Materials 
All restriction endonucleases were purchased from United State Biochemical 
(USB), Bethesda Research Laboratory (GIBCO BRL), or Promega; T4 DNA ligase, 
Exonuclease III, and S 1 Nuclease were from Promega; the BIOPRIME™ DNA Labeling 
System was purchased from GIBCO BRL; the pAl plasmid containing the rabbit eiF-2B£ 
eDNA was obtained from this lab (Dr. Agatha Asuru); the human histiocytic lymphoma 
(U-937) cell eDNA library constructed in A.gtlO was a gift kindly provided by Dr. N. 
Shaun B. Thomas (University College London); the bacterial strain E. coli C600hfl (for 
lambda phage) was from Promega and MAX EFFICIENCY DH5a™ Competent Cells were 
from BRL; the 150 mm and 82 mm nylon membrane circles were from MagnaGraph 
(Micron Separations Inc.) and BRL, respectively; the streptavidin-alkaline phosphatase 
(SA-AP) conjugate was bought from BRL; the 5' RACE kit for rapid amplification of 
eDNA 5' Ends was purchased from GIBCO BRL; the human gene specific primer 1 
(hGSPl) was synthesized by Oklahoma State University Core Facility; the nested human 
gene specific primer 2 (hGSP2) was synthesized by National Biosciences Inc. (NBI); the 
human HeLa cell total RNA was from Clontech; the GeneAmpR PCR reagent kit with 
AmpliTaqR DNA polymerase was bought from Perkin Elmer Cetus Corp.; chemicals for 
color detection (NBT, Nitroblue Tetrazolium Chloride; BCIP, 5-Bromo-Chloro-3-
Indolylphosphate) were from Sigma; SequenaseR Version 2.0 DNA sequencing Kit was 
purchased from USB and dATPaS[35S] was from New England Nuclear Research 
products of DuPont; ultrapure sequencing reagents (urea, acrylarnide and bis-acrylamide) 
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were bought from USB. All other chemicals and reagents are from Sigma, USB, EM 
Science (of EM Industries, Inc.) or Fisher Scientific. 
Media prepared: LB medium is 1% (w/w) Bactotryptone, 1% (w/w) NaCl, and 
0.5% (w/w) yeast extract; LM agar is 1% (w/w) Bactotryptone, 0.5% (w/w) yeast extract, 
10 mM NaCl, 10 mM MgS04, and 1.5% agar; and TAXI plates are 5 j.!g/ml Thiamine, 
20 j.!g/ml ampicillin, 33j.Lg/ml X-gal, and 8.lj.!g/ml1PTG in LM agar. 
20 X sse is 3.0 M NaCl and 0.3 M sodium citrate, pH 7 .0. 
Methods 
Nonradioactive (Biotin-14--dCTP) Labeling of DNA Probes 
The 2.5 kb rabbit reticulocyte eiF-2BE eDNA was digested out as aBamHI-Hindlii 
(USB) fragment from about 10 jlg of CsCl-EtBr gradient purified pAl plasmid which 
contains the eDNA inserted into the EcoRl site of the pBluescript vector. The digestion 
product was separated on a 0.8% agarose gel. The 2.5 kb eDNA insert was excised from 
the gel, and the DNA was then recovered by the freeze-squeeze method as described (83). 
Using the BIOPRIME™ DNA labeling system (GIBCO BRL), this 2.5 kb insert was then 
non-radioactively labeled with biotin-14--dCTP via the random priming method according to 
manufacturer's suggestion. 
Screening the Human A.gtlO eDNA Library 
About 500,000 phages from a human histiocytic lymphoma (U -937) cell eDNA 
library constructed in A.gtlO were plated out on C600hjl (Promega) lawns at a density of 
about 50,000 pfu per 150 mm plate (84). The plates were kept at 37°C for 9-16 hours until 
the plaques just touched. After chilling the plates at 4°C for 2 hours, plaques from each 
plate were transferred to a pair of nylon membranes (MagnaGraph) as previously described 
(84). Each membrane was then washed successively with 0.5 N NaOH containing 1.5 M 
16 
NaCl; 0.5 M Tris-HCl (pH 8.0) containing 1.5 M NaCl; and 2 X sse (84), respectively. 
The plaque DNA was then cross-linked to the membranes by UV cross-linking. The 
prehybridization (4 hours) and hybridization (overnight, >12 hours) were carried out in the 
presence of 50% formamide at 42°C according to the protocol provided by PHOTOGENE 
(GIBCO BRL) non-radioactive nucleic acid detection system. Binding the streptavidin-
alkaline phosphatase conjugate (GIBCO BRL) was carried out according to PHOTOGENE 
protocol and detection of biotin-labeled probe DNA-target DNA hybrids was done 
according to a protocol from the Nonradioactive DNA Labeling and Detection Kit from 
Boehringer-Mannheim. 
Positive plaques were picked out from the original plates as described (84). 
Secondary screening was done essentially the same way as the primary screening, except 
that plaque density was reduced to below 500 pfu per 80 mm plate. Well resolved plaques 
were then isolated and stored individually. 
Dot Blot Analysis of Positive Lambda Plaques 
Each positive lambda isolate was grown as described (84) in a small-scale liquid 
culture until lysis occured. Then 5 J..Ll of supernatant from each lysate was spotted on a 
nylon filter. This filter was then treated exactly the same as in the "library screening" 
section. For positive control, 800 pg of pAl plasmid was also spotted. A randomly 
selected A.gtlO phage was also included as negative control. 
Subcloning into Sequencing Vector pBluescript SK( +) 
Isolation of lambda phages was performed as described (84). About 1 J..Lg of each 
phage DNA was digested completely by EcoRI. The digestion products were separated on 
a 0.8% agarose gel. Only the phage with the largest insert was chosen to be subcloned. 
Since the largest insert had an internal EcoRI site, partial digestion was performed 
at 37°C for 20 minutes with 1 J..Lg of A. DNA being digested by 20 units of EcoRI (USB). 
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The digestion product was separated on a 0.8% agarose gel, and the DNA band 
corresponding to the intact insert was excised from the gel. The insert DNA was recovered 
(83) and subsequently ligated into the pBluescript vector as described (84). 
Transformants were screened on TAXI plates. Several white colonies bearing 
inserts were randomly isolated and their plasmid DNAs were further characterized by 
restriction endonuclease (EcoRI, BamHI and Hindill) digestion. 
Southern Blotting to Check Insert Identity 
Lambda DNA and plasmid DNA were digested by appropriate restriction 
endonucleases (EcoRI, BamHl or Hindiii). The digestion products were separated on a 
0.8% agarose gel. After staining by EtBr and photography, the gel was treated once in 
0.25 M HCl for 15 minutes for depurination, twice in 0.5 N NaOH containing 1.5 M 
NaCl for 20 minutes to denature the DNA, and twice in 1.0 M Tris·HCl containing 1.5 M 
NaCl for 20 minutes to neutralize the gel. The DNA was then transferred onto a nylon 
membrane as described in PHOTOGENE protocol. Hybridization with biotin-14-dCTP 
labeled eDNA probe, binding of SA-AP conjugates, and color detection reaction were 
performed exactly the same way as that in the "library screening" section. 
Generating Unidirectional Deletions to Facilitate Sequencing 
To facilitate fast sequencing of relatively large inserts with one (or two) primer(s), a 
series of unidirectional deletions (Exo III library) were generated according to "Protocols 
and Applications Guide" (2nd Edition) from Promega. The recombinant pBluescript 
containing insert was first linearized by Kpni (GIBCO BRL) and EcoRV (USB) and then 
extracted with TE-saturated phenoVchloroform. The DNA was then precipitated and 
redissolved in Exo III buffer (66 mM Tris·HCl, pH 8.0; 0.66 mM MgCl2). Exo III 
deletion at 37°C, ligation and transformation procedures were exactly the same as described 
in the protocol with each sample being taken out at a 30 second interval. 
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The progressive deletion process was checked on a 0.8% agarose gel as 
recommended. The transformants selected from different LB plates were further 
characterized by isolating plasmid DNA and restriction endonuclease digestion. This 
process can be continued until a series of plasmids with satisfactory (200-300 bp shorter) 
lengths are obtained. The same procedure was used to generate another Exo ill library from 
another recombinant pBluescript plasmid bearing the same insert but with a different 
orientation. The same restriction endonucleases (Kpnl and EcoR V) were used in this case. 
Sequencing 
Nucleic acid sequencing using dideoxy method was carried out with a SequenaseR 
Version 2.0 DNA Sequencing Kit from U. S. Biochemical Corp. (Cleveland, Ohio) and 
dATPaS[35S] (NEN-DuPont) as recommended by manufacturer. Sequences for both 
strands were obtained by this method from the two Exo ill libraries described above. 
5' RACE (Rapid Amplification of 5' eDNA End) 
In an attempt to get the missing 5' end of the human eDNA, a combined approach 
of reverse transcription and PCR called 5'-RACE (Rapid Amplification of 5'-cDNA Ends) 
was employed by using the 5' RACE Kit bought from GIBCO BRL. The whole procedure 
was performed according to the manufacturer's recommendation. Briefly, available 
sequence information downstream of the internal EcoRI site was used to synthesize a 
human gene specific primer (hGSPl). After priming the first strand eDNA synthesis from 
1 11-g of human HeLa cell total RNA (Clontech) with this hGSPl, RNA templates were 
digested away with RNaseH. The eDNA purified by GLASSMAXR DNA Isolation Spin 
Cartridge was then tailed with dCTP by Terminal deoxynucleotidyl Transferase (TdT) and 
served as the PCR template for an anchor primer (with a complementary poly(dG) tail) and 
a nested gene specific primer 2 (hGSP2). PCR reaction conditions were 94°C for 45 
seconds, 57°C for 25 seconds, and 72°C for 2 minutes. This cycle was repeated 35 times 
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followed by 8 minutes final extention at 72°C. PCR products were analyzed on a 0.8% 
agarose gel. Southern blotting of the gel and subsequent hybridization with eiF-2BE 
specific probes and color development were the same as those in the "Southern Blotting" 
section. 
Data Analysis 
Sequencing data were analyzed by MacVector™ 4.0 software on a Macintosh 
computer. Genetics Computer Group (GCG) sequence analysis software package based on 
the University of Oklahoma VAX computer was employed for mRNA secondary structure 
prediction and the multisequence alignment 
CHAPTER IV 
RESULTS AND DISCUSSION 
Screening the Human AgtlO eDNA Library 
Twenty-three positive plaques were isolated from the primary screening from which 
13 well resolved single positive plaques were obtained during the secondary screening. Dot 
blot analysis on a nylon membrane circle indicated that they were all positive by showing 
strong color development. The negative control (a randomly selected lambda phage from 
the human eDNA library) did not have any color development, while the positive control 
(800 pg of pAl plasmid) showed strong color development (Fig. 1). Therefore, the 13 
individually isolated recombinant AgtlO phages all bore inserts which were somewhat 
similar to the rabbit reticulocyte eiF-2B£ eDNA. The different color intensities probably 
reflect different DNA amounts or different degrees of insert sequence similarity. 
Characterization of Inserts 
The human A.gtlO eDNA library was constructed so that foreign DNA is inserted 
into a unique EcoRI site on this recombinant vector. This EcoRI site cuts the 43.34 kb 
lambda DNA into a 32.71 kb left arm and a 10.63 kb right arm. All 13 recombinant phage 
isolates were digested by EcoRI to completion. The digestion products were separated on 
0.8% agarose gels (Fig. 2A and 2B). One isolate showed two insert bands whose 
approximate sizes were 0.5 kb and 2.3 kb, respectively. Nine isolates had 2.3 kb insert 
each. Inserts for the other two isolates were around 1.6 kb, although slight 
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Figure 1. Dot blotting assay of 13 positive phage plaques. 
From upper left comer to lower right comer, the spotted 16 samples are: 
phage isolates 1-21-1, 1-31-1, 1-41, 1-51, 2-11, 2-21, 3-11, 3-21, 3-31, 
3-41, 4-11, 6-31, 7-11, 9-11, negative control (a randomly selected 
recombinant lambda phage), and positive control (800 pg pAl plasmid), 
respectively. For each phage isolate, 5 ~1 of supernatant from small scale 
phage growth lysate was spotted on the nylon membrane as described in the 
text. The phage isolate 1-21-1 was later shown to have contained the largest 
2. 8 kb insert. 
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Figure 2. EcoRl digestion of the 13 positive lambda phage isolates. 
(A) EcoRl digestion of phage 1-21-1. Lane 1, undigested 50 kb re1 
binant phage DNA. Lane 2, EcoRl digested 1-21-1. A 0.5 kb insert ba 
visible in the original film. Lane 3, 1 kb DNA ladder (GIBCO B 
(B) EcoRl digestion of the other 12 positive phage isolates. Lanes 1, 8, 
are 1 kb DNA ladders (BRL). Lanes 2-7 and 10-15 are phage isolates· 
6-31 , 4-11 , 3-41 , 3-31 , 3-21, 3-11 , 2-21, 2-11, 1-51 , 1-41 , and 1-: 
respectively. 
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differences in length exist. The digestion product of one isolate did not appear to have a 
detectable insert band. 
Restriction enzyme analysis indicated that the largest insert was about 2.8 kb, and 
had an internal EcoRI site that cuts the insert into a 0.5 kb and 2.3 kb fragments. The 
2.3 kb fragment is the same as the inserts of the other 9 isolates. It was not clear what the 
two isolates with 1.6 kb inserts were, but it was probable that they were truncated versions 
of the 2.3 kb insert. The isolate which did not contain an insert was odd, since A.gtlO phage 
without an insert are difficult to grow on the C600hjl host strain. 
Subcloning into the Sequencing Vector 
Since the phage isolate with the largest insert had an internal EcoRI site, partial 
digestion by EcoRI was employed to retrieve the intact insert from the lambda vector. 
Digestion at 37°C for 20 minutes with 20 units of EcoRI (USB) seemed to give the highest 
yield of the intact insert from 1 !lg of A DNA (Fig. 3). The DNA bands corresponding to 
the intact insert were then excised from the gel. The DNA was recovered by freeze-squeeze 
method (83) and ligated into pBluescript SK(+) vector at its EcoRl site. 
Transformation using MAX EFFICIENCY DH5a™ Competent Cells (BRL) was 
highly efficient (> 1000 colonies formed with about 1 ng input DNA) and about 1/4 of the 
colonies were white on the TAXI plates. Ten white colonies were picked (84). Of the eigh t 
plasmids whose DNAs were isolated, all contained the expected 2.8 kb insert, since EcoRl 
digestion of the plasmids yielded 0.5 kb and 2.3 kb insert bands in addition to the 3.0 kb 
vector band (Fig. 4). Two plasmids, designated pBRFA and pBRFI, were further 
characterized by restriction endonuclease digestion (Hindlll, etc.) and were confirmed to 
have the same insert with different orientations (Fig. 5). 
Figure 3. Partial EcoRI digestion of recombinant lambda phage isolate 1-21-1. 
Lanes 1 to 7 are different loads of the same digestion reaction. Lane 8 
1 kb DNA ladder (BRL). A total of 1 ).lg of phage DNA was subjectec 
unit of EcoRI (USB) partial digestion at 37°C for 20 minutes. The 
2.8 kb intact insert band was subsequently recovered from the g« 
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Figure 4. Characterization of 10 randomly selected white transformants from TAXI 
by EcaRI digestion. 
Lanes 1, 9, 15, and 23 are supercoiled pBluescript SK(+) plasmid 
Lanes 6, 14, 20, and 28 are 1 kb DNA ladders (BRL). Lanes 2, 4, 
12, 16, 18, 21, 24, and 26 are supercoiled forms of recombinant pl 
DNAs prepared from transformants A, B, C, D, E, F, G, H, I, < 
respectively. Their corresponding EcoRI digestion products are in lane 
8, 11, 13, 17, 19, 23, 25, and 27, respectively. No DNAs seem 
present in lanes corresponding to samples G and H probably bee<= 
mistake occured during the plasmid isolation step. All other samples c' 
the expected 2.8 kb insert since EcoRI digestion yielded two insert 
(0.5 kb and 2.3 kb) in each case. Two plasmids, pBRFA and f 
(from A and I respectively), were chosen for further characteri2 
sc: supercoiled DNA; M: 1 kb ladder. 
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Figure 5. Characterization ofpBRFA and pBRFI by restriction endonuclease diges 
Lanes 1, 6, and 13 are 1 kb DNA ladders (BRL). Lane 2, Psti 
digestion of pBRFI. Lane 3, Hindiii (USB) digestion of pBRFI. I 
BamHI (USB) digestion of pBRFI. Lane 5, EcoRI linearized pBlu 
SK(+) vector DNA. lane 7, supercoiled DNA ofpBRFI. Lane 8, supe 
DNA of pBluescript SK( + ). Lane 9, Supercoiled DNA of pBRFA. L 
Psti (BRL) digestion of pBRFA. Lane 11 , Hindiii digestion of p: 
Lane 12, BamBI digestion of pBRFA. Note that Hindiii digesti 
pBRFA and pBRFI gave different band patterns, indicating di 
orientations of insert in these two plasmids. M: 1 kb ladder; P: P 
Hindiii; B: BamHI; sc: supercoiled DNA. 
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To further confirm that pBRFA and pBRFI contain the target eDNA inserts, 
Southern blotting was performed. The lambda phage from which the 2.8 kb insert was 
isolated, and plasmids pBRFA and pBRFI were digested with restriction endonucleases as 
indicated (Fig. 6A). Southern blotting (Fig. 6B) indicated that all bands (except one, see 
below) related to the insert fragment hybridized strongly with the eiF-2B£ eDNA specific 
probe, implying sequence homology. But quite unexpectedly, the 0.5 kb fragment derived 
from the insert did not hybridize with the probe. The reason is explained below. In 
addition, the pUC plasmid related vector bands (including pBluescript SK( +) and the 
vector used in the commercial product 1 kb DNA ladder from BRL) unexpectedly 
hybridized strongly with the eiF-2B£ specific probe. It is unlikely that the probe prepared is 
nonspecific (so that it detects all DNA bands) because of the following reasons: 
1) The probe does not hybridize with A.gtlO arms. The hybridization band near the 
right arm is the incomplete digestion product of A.gtlO DNA which contains the 2.3 kb 
eDNA fragment. The 10.63 kb right arm does not hybridize with the probe at all. The 
broad band at the 32.71 kb left arm position is likely due to the presence of incomplete 
digestion product. 
2) The probe does not hybridize with the 1 kb DNA ladder which is derived from 
the yeast 2~ plasmid. 
3) The probe does not hybridize with other numerous foreign insert cDNAs in the 
A.gtlO library, since this probe was used to isolate 13 individual lambda plaques from the 
eDNA library, which all seem to contain the same insert DNA. 
4) The probe does not hybridize with the 0.5 kb insert band derived from the intact 
2.8 kb insert. Given the sensitivity of this method which can detect homologous DNA at 
levels of less than 1 pg, all DNA bands detectable in EtBr stained gel (> 10 ng) should 
Figure 6. Southern blotting to check the identity of the 2.8 kb insert. 
(A) Lanel , the 2.5 kb rabbit eiF-2BE eDNA insert isolated from pA: 
BamHI- Hindlll fragment. Lane 2, Hindlll digestion of pBRFI. L2 
Hindiii digestion of pBRFA. Lane 4, Bamm digestion of pBRFI. Lc: 
EcoRI digestion of pBRFA. Lane 6, EcoRI digestion of phage i~ 
1-21-1. Lane 7, phage isolate 1-21-1. Lane 8, 1 kb DNA Ladder (I 
(B) Southern blotting result of (A). Rabbit eiF-2BE eDNA specific p 
were used for hybridization. All lanes are in the same order as in (A). ( 
bands were present in the EcoRI digestion of pBRFA and lambda 
(lanes 5 and 6), but no corresponding hybridization bands apeared : 
Southern blotting result. 
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hybridize strongly with the probe if they are homologous. In fact, it is this result that gave 
us the first hint that the 0.5 kb insert might not be related to human eiF-2Be eDNA (see 
"Sequence and Data Analysis" part below). 
5) The reasons cited above do not rule out the possible existence of minor amounts 
of contaminating vector DNA in the gel purified 2.5 kb rabbit eiF-2B£ eDNA preparation 
used to generate the probe. While this contamination could be hard to avoid when trying to 
excise the 2.5 kb insert band which migrates close to the 3.0 kb vector band, it should be 
fairly easy to avoid when excising the 5' end 230 bp EcoRI fragment of rabbit eiF-2B£ 
eDNA. Yet even this DNA preparation gave a probe that hybridized strongly with those 
pUC related vectors (data not shown). 
6) A eukaryotic probe derived from yeast 2J.l plasmid has similarly been found to 
cross-hybridize with prokaryotic DNA vector pBR322 (85). This had been attributed to the 
possible sequence similarity between the probe and the vector, although it was later shown 
by computer search that no extensive identities exist and that the longest perfect identity 
was only 13 base pairs (86). 
Generating Unidirectional Deletions to Facilitate Sequencing 
Preliminary sequencing data revealed that one end of the 2.8 kb insert had a long 
stretch of poly(A) sequence (> 100 bp) which was impossible for the SequenaseR Version 
2.0 T7 DNA Polymerase (USB)to pass through. To overcome this problem, a series of 
unidirectional deletions were made from both the pBRFA and pBRFI plasmid. The deletion 
products were monitored by withdrawing ongoing reactions at different times. The 
electrophoresis of the reaction products is shown in Fig. 7 A Because the reaction rate can 
not be predicted accurately, the reaction was repeated for a specific time period in order to 
get proper deletion products. Because of the heterogeneity of the reaction, plasmid 
transformants from the same plate do not necessarily have the same size. Abnormal 
plasmids may also appear. So after the general characterization of various deletions by 
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plasmid isolation and enzyme digestion (Fig. 7B and 7C), additional rounds of plasmid 
isolation and enzyme digestion were required to obtain the expected deletion products. 
Finally, two series of unidirectional deletions were made with 200-350 bp insert length 
differences between two successive plasmids. 
Sequencing and Data Analysis 
Sequencing reactions were performed using the SequenaseR Version 2.0 DNA 
sequencing kits from U. S. Biochemical Corp. (Cleveland, Ohio). Overlapping pieces of 
DNA sequences were used to reconstruct the complete sequence using the MacVectorTM 4.0 
program in a Macintosh computer. Sequences for both strand were obtained and they 
agreed with each other (Fig. 8). 
Sequencing data confirm that the 0.5 kb EcoRI fragment is totally unrelated to the 
eiF-2BE eDNA. It was probable that this fragment was ligated to the 2.3 kb partial eDNA 
of human eiF-2BE eDNA merely by chance during the construction of the library. This is 
supported by the fact that human eiF-2BE eDNA is nearly 90% identical to its rabbit 
reticulocyte counterpart up to the internal EcoRl site. But when the sequence goes further 
upstream beyond this site, an additional poly(A) sequence appears, followed by a sequence 
which shows virtually no homology with the 230 bp rabbit eiF-2BE eDNA 5' end. This is 
unlikely to be the case if the 0.5 kb fragment is part of the human eiF-2BE eDNA, since the 
most conserved region between the rabbit eiF-2BE eDNA and its proposed yeast 
counterpart GCD6 eDNA resides at the 5' end (81). 
Starting from the internal EcoRI site, the partial human eiF-2BE eDNA contains a 
single large open reading frame which starts at base 301 and ends at base 1926. This open 
reading frame will encode a peptide of 541 amino acid residues. If the average molecular 
weight of an amino acid residue is taken to be 110 Da, the molecular weight of this protein 
is less than 60 kDa, far less than the reported 82 kDa value. Furthermore, no in-frame stop 
codons have been observed in the upstream 300 bases, so it is quite certain that 
Figure 7. Generation of the unidirectional deletions (Exo ill library). 
(A) Monitoring the progressive Exonuclease III digestion reaction. S: 
were withdrawn at 30 second intervals. The left and right mos1 
are 1 kb DNA ladders (BRL). Upper half, pBRFA; lower half, I 
(B) BamHI digestion of Exo III libraries for pBRFA and pBRFI. Upp4 
Lane M, 1 kb DNA ladder (BRL). Lane 13, BamBI digestion of pl 
Lanes 1-12, BamHI digestion ofpBRFA Exo III library. Lower halJ 
M, 1 kb DNA ladder. Lane 13, BamBI digestion of pBRFI. Lane: 
BamBI digestion of pBRFI Exo ill library. (C) HindiiT digestion of : 
libraries for pBRF A and pBRFI. Lane assignments were the same as 
Note that some individual members of the library are abnormal and th1 
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Figure 8. Nucleotide and Amino Acid Sequences of Human eiF-2Bc: Subunit. 
The EcoRI site and the first in-frame A TO start codon are underline 
A TT AAA sequence which is very close to the consensus sec 
(AAT AAA) for adding poly( A) tail is in bold letter. Amino aci 
represented by one-letter-code (singlet). 
~CTGACTGCCACAGGTGTACAGGAAACATTTGTCTTTTGTTGCTGGAAAGCTGCTCAAATCAAAGAACATTTA 78 
E F L T A T G V Q E T F V F C C W K A A Q I K E H L 
CTGAAGTCAAAGTGGTGCCGCCCTACATCTCTCAATGTGGTTCGAATAATTACATCAGAGCTCTATCGATCACTGGGA 156 
L K S K W C R P T S L N V V R I I T S E L Y R S L G 
GATGTCCTCCGTGATGTTGATGCCAAGGCTTTGGTGCGCTCTGACTTTCTTCTGGTGTATGGGGATGTCATCTCAAAC 234 
D V L R D V D A K A L V R S D F L L V Y G D V I S N 
ATCAATATCACCAGAGCCCTTGAGGAACACAGGTTGAGACGGAAGCTAGAAAAAAATGTTTCTGTGATGACGATGATC 3 12 
I N I T R A L E E H R L R R K L E K NV S VJ:iT M I 
TTCAAGGAGTCATCCCCCAGCCACCCAACTCGTTGCCACGAAGACAATGTGGTAGTGGCTGTGGATAGTACCACAAAC 390 
F K E S S P S H P T R C H E D N V V V A V D S T T N 
AGGGTTCTCCATTTTCAGAAGACCCAGGGTCTCCGGCGTTTTGCATTTCCTCTGAGCCTGTTTCAGGGCAGTAGTGAT 468 
R V L H F Q K T Q G L R R F A F P L S L F Q G S S D 
GGAGTGGAGGTTCGATATGATTTACTGGATTGTCATATCAGCATCTGTTCTCCTCAGGTGGCACAACTCTTTACAGAC 546 
G V E V R Y D L L D C H I S I C S P Q V A Q L F T D 
AACTTTGACTACCAAACTCGAGATGACTTTGTGCGAGGTCTCTTAGTGAATGAGGAGATCCTAGGGAACCAGATCCAC 624 
N F D Y Q T R D D F V R G L L V N E E I L G N Q I H 
ATGCACGTAACAGCTAAGGAATATGGTGCCCGTGTCTCCAACCTACACATGTACTCAGCTGTCTGTGCTGACGTCATC 702 
M H V T A K E Y G A R V S N L H M Y S A V C A D V I 
CGCCGATGGGTCTACCCTCTCACCCCAGAGGCGAACTTCACTGACAGCACCACCCAGAGCTGCACTCATTCCCGGCAC 780 
R R W V Y P L T P E A N F T D S T T Q S C T H S R H 
AACATCTACCGAGGGCCTGAGGTCAGCCTGGGCCATGGCAGCATCCTAGAGGAAAATGTGCTCCTGGGCTCTGGCACT 858 
N I Y R G P E V S L G H G S I L E E N V L L G S G T 
GTCATTGGCAGCAATTGCTTTATCACCAACAGTGTCATTGGCCCCGGCTGCCACATTGGTGATAACGTGGTGCTGGAC 936 
V I G S N C F I T N S V I G P G C H I G D N V V L D 
CAGACCTACCTGTGGCAGGGTGTTCGAGTGGCGGCTGGAGCACAGATCCATCAGTCTCTGCTTTGTGACAATGCTGAG 1014 
Q T Y L W Q G V R V A A G A Q I H Q S L L C D N A E 
GTCAAGGAACGAGTGACACTGAAACCACGCTCTGTCCTCACTTCCCAGGTGGTCGTGGGCCCAAATATCACGCTGCCT 1 092 
V K E R V T L K P R S V L T S Q V V V G P N I T L P 
GAGGGCTCGGTGATCTCTTTGCACCCTCCAGATGCAGAGGAAGATG~AGATGATGGCGAGTTCAGTGATGATTCTGGG 1170 
E G S V I S 1 H P P D A E E D E D D G E F S D D S G 
GCTGACCAAGAAAAGGACAAAGTGAAGATGAAAGGTTACAATCCAGCAGAAGTAGGAGCTGCTGGCAAGGGCTACCTC 1248 
A D Q E K D K V K M K G Y N P A E V G A A G K G Y L 
TGGAAAGCTGCAGGCATGAACATGGAGGAAGAGGAGGAACTGCAGCAGAATCTGTGGGGACTCAAGATCAACATGGAA 1 326 
W K A A G M N M E E E E E L Q Q N L W G L K I N M E 
GAAGAGAGTGAAAGTGAAAGTGAGCAAAGTATGGATTCTGAGGAGCCGGACAGCCGGGGAGGCTCCCCTCAGATGGAT 1404 
E E S E S E S E Q S M D S E E P D S R G G S P Q M D 
GACATCAAAGTGTTCCAGAATGAAGTTTTAGGAACACTACAGCGGGGCAAAGAGGAGAACATT'I'CTTGTGACAATCTC 1482 
D I K V F Q N E V L G T L Q R G K E E N I S C D N L 
GTCCTGGAAATCAACTCTCTCAAGTATGCCTATAACGTAAGTCTAAAGGAGGTGATGCAGGTACTGAGCCACGTGGTC 1 560 
V L E I N S L K Y A Y N V S L K E V M Q V L S H V V 
CTGGAGTTCCCCCTGCAACAGATGGATTCCCCGCTTGACTCAAGCCGCTACTGTGCCCTGCTGCTTCCTCTGCTAAAG 1 638 
L E P P L Q Q M D S P L D S S R Y C A L L L P L L K 
GCCTGGAGCCCTGTTTTTAGGAACTACATAAAGCGCGCAGCCGACCATTTGGAAGCGTTAGCAGCCATTGAGGACTTC 17 16 
A W S P V P R N Y I K R A A D H L E A L A A I E D F 
TTCCTAGAGCATGAAGCTCTTGGTATTTCCATGGCCAAGGTACTGATGGCTTTCTACCAGCTGGAGATCCTGGCTGAG 1 79 4 
F L E H E A L G I S M A K V L M A F Y Q L E I L A E 
GAAACAATTCTGAGCTGGTTCAGCCAAAGAGATACAACTGACAAGGGCCAGCAGTTGCGCAAGAATCAACAGCTGCAG 1672 
E T I L S W P S Q R D T T D K G Q Q L R K N Q Q L Q 
AGGTTCATCCAGTGGCTAAAAGAGGCAGAAGAGGAGTCATCTGAAGATGACTGAAGTCACACTGCCTGCTCCTTTGGG 1950 
R P I Q W L K E A E E E S S E D D * 
TGTGATTGAGTGCCCTCCTGGCTCCTGGGCTGGGACAAGTGAGGAACTAGCTGCAGAGGGATGAGTGACCACCATCCA 2 0 28 






sequence information at the 5' end of the intact mRNA for eiF-2BE (including part of the 
coding region and the 5' end untranslated region) has been lost. The loss of the 5' end is 
most likely due to insufficient methylation of the internal EcoRI sites while constructing the 
eDNA library. Since the cDNAs were size selected before ligation into the A.gtlO vectors 
and none of the 13 individually selected recombinant phages contained the full length 
eiF-2BE eDNA, rescreening the same eDNA library to search for that missing 5' end is 
unlikely to be worthwhile. Either other approaches or rescreening other better human 
eDNA libraries might be employed to get the full length eDNA. 
Alignment of three sequences, human and rabbit eiF-2BE proteins together with 
their yeast counterpart GCD6 sequence, was done by using the Genetics Computer Group 
(GCG) sequence analysis software package (87) (Fig. 9). The consensus sequence of the 
three proteins showed that the N-terminus was more conserved. Also, downstream from 
the internal EcoRI site, human and rabbit eDNA show strong sequence similarity (about 
90% identity, data not shown). Only the 3'-untranslated region has several insertions or 
deletions which are not observed within the coding region. These data further support the 
notion that these three homologous sequences encode eiF-2BE subunit. 
5' RACE (Rapid Amplification of 5' eDNA End) 
Attempts to amplify the 5' end of the eiF-2BE mRNA using a 5'-RACE kit from 
BRL have not been successful. A single 340 bp hybridization band was detected after 
southern blotting the PCR product (Fig. 10). The two "x" arrows in Fig. lOB and lOC 
seem to point to the same band, but careful examination revealed that the "x" in Fig. lOB 
actually corresponded to the white marks just above the "x" in Fig. lOC. The hybridization 
band in Fig. lOC was real. However, its corresponding DNA band in the gel can not be 
seen, indicating that the PCR product of interest is present at such a low level that it will be 
difficult to clone. Even if it were cloned, it still may not give us a full length eDNA. This 
problem probably arises from the fact that the 5' end of the mRNA is very GC-rich; the 
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first 150 bases at the 5' end of the cloned rabbit eDNA is > 80% GC. To investigate this 
issue further, a computer program of the GCG package was used to predict the potential 
mRNA secondary structures within the first 230 bases of the rabbit eiF-2Be sequence. The 
results (Fig. 11) show that a set of very stable secondary structures potentially exists within 
this region. For the first very GC-rich 100 bases, a 13 bp double helix structure exists with 
a free energy of -43.6 Kcal/mol at 37°C and -2.4 Kcal/mol at 100°C! As a control, the 
average free energy for a 100 base RNA sequence is just around -20 Kcal/mol and virtually 
all structures melt out at about 75°C. Since the SUPERSCRIJ>TTM reverse transcriptase 
provided with the BRL kit is only active at temperatures below 45°C, the stable mRNA 
secondary structures present at that temperature may prevent the enzyme from reverse 
transcribing through this region. However, this problem might be alleviated by using a 
reverse transcriptase (Retrotherm™ RT DNA Polymerase from Epicentre Technologies, 
Madison, Wisconsin) which functions at 70°C or above. 
Figure 9. Three-way Alignment of Human, Rabbit and Yeast eiF-2B£ Proteins. 
The three-way alignment was generated by using progressive pa 
alignment. Numbers are arbitrary units for blocks, periods represen 
inserted in the sequence, and asterisks occur at the C terminus oJ 
sequence. a consensus sequence is shown below the yeast sequence; 
case letters indicate that three sequences are identical at that positioJ 
lower case letters indicate that two of the three sequences are identical. 
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1 70 
Prn-Hum . . ........ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . • • • • 0 ••••• . . . . . . .. . . • ••• •• • 0 •• 
Prn- Rab ... RPPPPGA VSDRANKRGG GPGGGGGGGG ARGAEEESPP PLQAVLVADS FNRRFFPISK DQPRVLLPLA 
Prn-Yst ..... . . . .. . .... MAGKK GQKKSGLGNH GKNSDMDVED RLQAVVLTDS YETRFMPLTA VKPRCLLPLA 
Cons ens . . . . . . . . . . . . . . . . . . . . g .... g.g .. . .. .... . .. . lqav .. . ds ... rf. p . . . .. pr.llpla 
71 140 
Prn-Hum ...... .. . E FLTATGVQET FVFCCWKAAQ IKEHLLKSKW CRPTSLNVVR IITSELYRSL GDVLRDVDAK 
Prn - Rab NVALIDYTLE FLTATGVQET FVFCCWKAAQ IKEHLQKSKW CRPTSLNVVR IITSELYRSL GDVLRDVDTK 
Prn-Yst NVPLIEYTLE FLAKAGVHEV FLICSSHANQ INDYIENSKYI NLPWSPFKIT TIMSPEARCT GDVMRDLDNR 
Cons ens nv.li .ytlE FLtatGVqEt FvfCcwkAaQ Ikehl . kSKW crPtSlnvvr iitSelyRs l GDVlRDvD.k 
141 210 
Prn-Hum ALVRSDFLLV YGDVI SNINI TRALEEHRLR RKLEKNVSVM TMIFKESSPS HPTRCHEDNV VVAVDSTTNR 
Prn-Rab ALVRSDFLLV YGDVVSNI NV TRALEEHRLR RKLEKNVSVM TMI FKESSPS HPTRCHEDNV VVAVDSATNR 
Prn-Yst GIITGDFILV SGDVLTNIDF SKMLEFHK. K llliLQDKDHIS TMCLSKASTY PKTRTIEPAA FV .LDKSTSR 
Cons ens alvrsDFlLV yGDV . sNin . traLEeHrlr rkLeknvsvm TMifkesSps hpTRchEdnv vVavDs.TnR 
211 280 
Prn-Hum VLHFQK .. . . .TQGLRRFAF PLSLFQGSSD GVEVRYDLLD CHISICSPQV AQLFTDNFDY QT.RDDFVRG 
Prn- Rab ILHFQK .... .TQGLRRFSF PLSLFQGSGA GVEIRYDLLD CHISICSPQV AQLFTDNFDY QT . RDDFVRG 
Prn-Yst CIYYQDLPLP SSREKTSIQI DPELLDNVDE FV .IRNDLID CRIDICTSHV PLIFQENFDY QSLRTDFVKG 
Cons ens lhfQk .. . . . tqg l rrf. f plsLfqgs .. gVeiRyDLl D ChisiCspqV aqlFtdNFDY Qt.RdDFVrG 
28 1 350 
Prn-Hum LLVNEEILGN QIHMHVTAKE YGARVSNLHM YSAVCADVIR RWVYPLTPEA NFTDSTTQSC THSRHNIYRG 
Prn-Rab LLVNEEILGN QIHMHVTTRE YGARVSNLHM YSAVCADVIR RWVYPLTPEA NFTDSTAQSC THSRHNIYRG 
Pl:'n - Yst . VISSDILGK HIYAYLTD . E YAVRVESWQT YDTISQDFLG RWCYPLVLDS NIQD . . DQTY SYESRHIYKE 
Cons ens llvneeiLGn qihrnhvT .. E YgaRVsnlhm YsavcaDvir RWvYPLtpea NftDst. Qsc t hsrhniYrg 
351 420 
Pl:'n - Hum PEVSLGHGSI LEENVLLGSG TVIGSNCFIT NSVIGPGCHI GDNVVLDQTY LWQGVRVAAG AQIHQSLLCD 
Prn - Rab PEVSLGHGSI LEENVLLGSG TVIGSNCSIT NSVIGPGCCI GDNVVLDRAY LWKGVQVASG AQIHQSLLCD 
Prn-Yst KDVVLAQSCK IGKCTAIGSG TKIGEGTKIE NSVIGRNCQI GENIRIKNSF IWDDCI IGNN SI IDHSLIAS 
Cons ens peVsLghgsi leenvllGSG Tvi Gsnc . It NSVIGpgC . I GdNvvld . . y 11-l.gv .va.g aqihqSLlcd 
421 490 
Prn-Hum NAEVKERVTL KPRSVLTSQV VVGPNITLPE GSVISLHPPD AEEDEDDGEF SDDSGADQEK DKVKMKGYNP 
Prn-Rab HAEVKEQVTL KPHCVLTSQV VVGPNITLPE GSVISLHPPD AEEDEDDGQF SDDSGVNQAK EKAKLKGYNP 
Pr n - Yst NATLGSNVRL NDGC IIGFNV KIDDNMDLDR NTKISASP . . . . LKNAGSRH YDNESNEQFD QDLDDQTLAV 
Cons ens nAevke .VtL kp. cvl tsqV vvgpNitLpe gsviSlhPpd aeededdg . f s Ddsg . . Q. k . k. k.kgynp 
4 91 560 
Prn- Hum AEVGAAGKGY LWKAAGMNME EE .. . . .. . . EELQQNLWGL KINMEEESES ESE . . ... . Q SMDSEE PDSR 
Prn-Rab AEVGVAGKGY LWKAADMNTE KE .. . . ... . EELRQSLWGL TINEEEESET ESE .. .. .. R SMDSEELDSR 
Prn- Ys t SIVGDKGVGY IYESEVSDDE DSSTEACKEI NTLSNQLDEL YLSDDSISSA TKKTKKRRTM SVNSIYTDRE 
Cons ens aeVG . aGkGY l wkaa .mn . E . e .. .... .. eeL.q .LwgL . in . eeeSe. es e . . . . . . . SmdSee . Dsr 
561 63 0 
Pl:'n - Hum GGSPQMDDIK VFQNEVLGTL QRGKEENISC DNLVLE INSL KYAYNVSLKE V . . . . MQVLS HVVLEFPLQQ 
Prn - Rab AGS PQLDDIK VFQNEVLGTL QRGKE ES I SC DNLILEINSL KYAYNISLKE V ... . MQVLS HVVLEFPLQQ 
Prn-Yst EIDSEFED.E DFEKEGIATV ERAMENNHDL DTALLELNTL RMSMNVTYHE VRI ATITALL RRVYHFIATQ 
Cons ens . gspq.dDik vFqnEvlgTl qRgkEen isc Dnl .LEiNsL kyayNvslkE V . . .. mqvLs hvVleFplqQ 
631 700 
Prn-Hum MDSPLDSSRY CALLLPLLKA WSPVFRNYIK RAADHLEALA AIEDFFLEH . . EALGISMAK VLMAFYQLEI 
Prn - Rab MDSPLEANRY CALLLPLLKA WSPVFRNYIK RAADHLEALA AIEEFFLEH . . EALGTCI AK VLMGFYQLEI 
Prn- Yst 'l'LG PKDA .. . ... VVKVFNQ WGLLFKRQAF DEEEYIDLMN I IMEKIVEQS FDKPDLILFS ALVSLYDNDI 
Cons ens mdsPlda . ry calllpl lka WspvFrny ik r aadhleala a ieefflEh . . ealg .. . ak vLm . fYqlei 
7 01 74 7 
Prn - Hum LAEETILSWF SQRDTTDKGQ QLRKNQQLQR FIQWLKEAEE ESSEDD* 
Prn- Rab LAEETILSWF GQRDVTDKGR QLRKNQQLQR FIQWLKEAEE ESSEDD* 
Prn- Yst IEEDVIYKWW DNVSTDPRYD EVKK . . LTVK WVEWLQNADE ESSSEEE 
Cons ens laEetilsWf .qrdttdkg. qlrKnqqlqr f i qWLkeAeE ESSedd* 
Figure 10. 5' RACE Result 
(A) Schematic diagram of 5'-RACE. In case of human mRNA, hGSP 
(human Gene Specific Primer 1&2), Anchor Primer (AP), and/or Uni 
Amplification Primer (UAP) are used. "EcoRI" represents the internal J 
site of the cloned 2.8 kb human eDNA. The dotted line represen 
poly(C) tail. In case of control mRNA, cGSPl & 2 were used inste 
hGSPl & 2. In addition, a third cGSP3 was also used. Figures we 
drawn to scale. (B) 5'-RACE result of human and control mRNA. 1 
human HeLa cell total RNA was used for this experiment. Lane 1, 
control. Lane 2, no TdT control. Everything is the same as in Lanes 
except no TdT was added in the TdT tailing step. Lane 3 & 4, 5'-I 
result of human HeLa cell mRNA. Lane 5, control C. TdT tailed c 
eDNA was amplified by cGSP2 and AP. Lane 6, control B. Mter th 
strand eDNA synthesis of the control RNA, the resulting eDNA was pt 
by spin column cartridge and amplified by cGSP2 &3. Lane 7, cont 
Same as in control B except that no purification was done. Lane 8. 
DNA ladder. (C) Southern blotting of (B) using rabbit eiF-2B£ sp 
probes. All lane assignments were the same as in (B). Note that d 
arrow in (B) does not corresponds to that in (C). (See text for detail) 
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Figure 11. PotentialS' End mRNA Secondary Structures of Rabbit eiF-2BE 
The 5'-end 230 bp of rabbit eiF-2BE mRNA was plotted by m 
MFOLD program of the GCG package. The folding temperature we. 
The free energy unit was Kcal/mole. 
~ .. 
Squiggle plot of: [. Mfold]82-1_230bp.Hfold;1 April 29, 1993 20:58 
(Linear} MFOLD of: 82.Gcg T: 37.0 Check: 4937 from: 1 to: 230 April 28, 1993 22:16 





CONCLUSIONS AND FUTURE STUDIES 
Conclusions 
A 2312 bp partial eDNA encoding human eiF-2B£ (82 kDa) subunit has been 
cloned and analyzed. Sequence analysis shows that the human partial eDNA and its rabbit 
counterpart share significant sequence homology; approximately 90% identity for both 
nucleotide sequences and protein sequences have been observed. For the aligned 641 
amino acid residues, only 55 changes have been observed. Among them, 38 are 
conservative substitutions. Thus the overall similarity between human and rabbit peptide 
sequence is above 97%. 
Several lines of evidence from in vitro studies indicate that the rabbit eDNA 
encodes eiF-2BE: (1) the eDNA codes for an isopropylthio-galactoside-inducible 86 kDa 
fusion protein that reacts with the anti-eiF-2B antiserum on immunoblots; (2) the eDNA 
contains a single long ORF whose predicted amino acid sequence encompasses the 
sequence of a peptide isolated after partial hydrolysis of the purified eiF-2BE subunit; 
(3) translation in reticulocyte lysate of mRNA transcribed in vitro from the eDNA yields a 
3SS-labeled protein that comigrates with endogenous eiF-2BE (88). Because of the 
significant sequence homology observed, it is almost certain that the cloned partial human 
eDNA encodes human eiF-2BE subunit. However, it is still not certain whether translation 
of rabbit eiF-2BE mRNA starts at a non-AUG (GUG in this case) start codon or at an 
upstream AUG codon which has not yet been cloned. mRNA secondary structure 
prediction reveals that potential stable secondary structures exist at the 5' end of the 
mRNA. The unusual structure might play a role in the translation initiation if GUG is used 
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as the start codon. Preliminary results from this lab seem to favor this assumption (90). 
Because the human eDNA is highly homologous to the rabbit eDNA, it is very likely that 
these secondary structures also exist in human mRNA. Whether human eDNA uses GUG 
as start codon needs to be determined. 
Future Studies 
Theoretically, at least two approaches can be employed to obtain the lost 5' end 
coding region. One is to screen the appropriate genomic library which will not only give the 
5' end coding region but also the 5'-untranslated region. Once obtained, it may help to 
resolve the dispute whether translation of eiF-2B£ mRNA is initiated through a normal 
AUG codon or a non-AUG codon (in this case, a GUG codon) and help to identify the 
N-terminus of the mature peptide. Studies on the regulation of the gene expression will be 
possible if the upstream untranslated region and promoter region are available (For 
example, antisense RNA can be used to suppress eiF-2B£ expression if the 5' end 
sequence is obtained). 
In addition, the 5'-RACE (Rapid Amplification of 5'-cDNA Ends) procedure can be 
modliied to overcome the problems encountered. A reverse transcriptase (RetrothermTM RT 
DNA Polymerase from Epicentre Technologies, Madison, Wisconsin) which functions at 
70°C or above can substitute the SuperScript reverse transcriptase so that the reverse 
transcription can be carried out at a temperature high enough to melt most secondary 
structures. 
Site-directed mutagenesis can be performed by PCR to change the first postulated 
non-AUG start codon (GUG) to AUG. This mutant eDNA can be used in an in vitro 
transcription and translation system to check if the expression level of the full length 
translation product is increased; previous work in this lab reported that an 80 kDa in vitro 
translation product of the rabbit eiF-2B£ eDNA did exist, although at a low level. 
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Regulation of translation initiation factor gene expression during human T cell 
activation has been reported for eiF-2a, -4E, and -4A (89). Regulation of eiF-2B 
expression may also occur. In preliminary studies, western blot analysis indicated that the 
eiF-2BE levels increased upon mitogen stimulation ofT cells. eiF-2BE mRNA levels are 
currently being semi-quantitated by the RT-PCR method since the available sequence 
information allows us to synthesize eiF-2BE specific primers. 
Casein kinase II has been shown to be able to phosphorylate eiF-2Be subunit in 
vitro (42). It would also be of interest to see if this also happens in vivo and if the 
phosphorylation sites in both cases are the same. If these are true, then what is the possible 
signal transduction pathway that leads to the phosphorylation of eiF-2Be and how is it 
regulated? The cloning of this eiF-2BE eDNA will greatly facilitate such kind of 
investigation. 
The cloned eiF-2BE eDNA can be used to generate large amounts of proteins for 
monoclonal antibody production. The availability of these antibodies may help to determine 
the eiF-2B/elF-2 ratio in vivo, which is the primary value upon which the sequestrated 
model for global protein synthesis regulation is based. 
Partial peptide sequences for other eiF-2B subunits are available. These will be 
used to synthesize degenerate primers for PCR. The resulting gene fragment will be used to 
clone cDNAs encoding other eiF-2B subunits. Once available, their specific functions and 
mutual interactions can be studied in a greater detail. 
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